Literature DB >> 6479837

Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography.

H Okuda, H Obata, T Nakanishi, T Hisamitsu, K Matsubara, H Watanabe.   

Abstract

Using high-performance liquid chromatography combined with a column of immobilized 3 alpha-hydroxysteroid dehydrogenase, 15 bile acids, i.e., cholate, chenodeoxycholate, deoxycholate, lithocholate, ursodeoxycholate, and their five taurine conjugates and five glycine conjugates, were clearly separated and quantified in 38 patients with various hepatobiliary diseases and 9 normal controls. The serum levels of bile acids, both primary and total, were elevated in patients with liver disease, but did not differentiate between parenchymal disease and cholestasis. The ratio of cholate/chenodeoxycholate was significantly increased in cholestasis as compared with parenchymal liver injury. In primary biliary cirrhosis, the ratio of total glycine/taurine conjugates was decreased, with a marked increase of taurochenodeoxycholate. The bile acid pattern was distinctly different between extrahepatic cholestasis and primary biliary cirrhosis, which mainly reflects intrahepatic cholestasis. In acute hepatitis, there was a quick normalization of major taurine and glycine conjugates in the convalescent stage. Most of the major taurine and glycine conjugated bile salts were significantly elevated in cirrhosis, and the elevation of taurochenodeoxycholate was particularly marked in the decompensated state. Furthermore, the quantitative relationship between taurocholate and taurochenodeoxycholate in cirrhosis was reversed from that in acute hepatitis. These changes in absolute and relative concentrations of bile acids in various liver diseases perhaps reflect differing pathology and metabolism, and may prove diagnostic. Measurement of individual bile salts is easily and quickly done with this method, and may lend itself clinical application.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6479837

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.

Authors:  Y Adachi; T Nanno; T Itoh; Y Kurumi; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

2.  Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.

Authors:  MaryPeace McRae; Naser L Rezk; Arlene S Bridges; Amanda H Corbett; Hsiao-Chuan Tien; Kim L R Brouwer; Angela D M Kashuba
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

3.  Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile.

Authors:  Luisa De Sordi; M Adil Butt; Hayley Pye; Darina Kohoutova; Charles A Mosse; Gokhan Yahioglu; Ioanna Stamati; Mahendra Deonarain; Sinan Battah; Derren Ready; Elaine Allan; Peter Mullany; Laurence B Lovat
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

4.  Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids.

Authors:  Leila Valanejad; Christina Nadolny; Stephanie Shiffka; Yuan Chen; Sangmin You; Ruitang Deng
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.